Muira Puama — Benefits Deep Dive

Muira puama is sold as "potency wood," an Amazonian aphrodisiac and nerve tonic with more than a century of reputation behind it. This deep dive takes each of its claimed benefits seriously enough to examine properly — and the examination has to begin somewhere unusual, because "muira puama" is a trade name rather than a botanical one.

At least three names are in play. Ptychopetalum olacoides is the species usually intended and the one behind essentially all the modern pharmacology. Ptychopetalum uncinatum circulates in the same trade under the same common names. And Liriosma ovata appears throughout the older pharmacy literature as the botanical source of the same commercial article. The traded material is chipped or powdered bark and root-wood — the hardest botanical material of all to identify once processed — moving through a wild-harvest supply chain with almost no authentication anywhere in it.

That is not a technicality to be cleared away before the interesting part. It is load-bearing. Every claim below is a claim about a specific plant producing a specific chemistry, and where the plant is uncertain the claim inherits the uncertainty. Worse, the usual reassurance does not help: a marker-compound assay is a potency check, not an identity check, and muira puama's commonly assayed constituents are pan-plant compounds that could not distinguish one candidate species from another. So the honest reading of an identity problem runs the opposite way from the one you usually see — it does not clear the plant, it indicts the product.

What follows is an attempt to be genuinely useful about a herb whose evidence is thin, without either dismissing it or inflating it. Two findings are worth flagging before you start, because they are the ones most likely to change how you read everything else. First, the libido claim — the reason nearly everyone arrives — has no adequate human evidence at all, and that is absent evidence rather than refuted evidence. Second, and more surprisingly, this plant's best science has nothing to do with the claim it is sold on: there is a coherent, multi-year body of preclinical neuropharmacology on acetylcholinesterase inhibition, memory and stress, which maps onto the traditional "nerve tonic" description far better than onto the bedroom.

Table of Contents

1. Deep-Dive Articles
2. The Evidence Ledger at a Glance
3. How to Read This Deep Dive
4. Key Research: Botanical Identity and Authentication
5. Key Research: The Sexual-Function Claim
6. Key Research: Central Nervous System Pharmacology
7. Key Research: Chemistry and the Missing Active Principle
8. Key Research: Safety, Toxicology and Adulteration
9. External Resources
10. Connections

Deep-Dive Articles

Back to Table of Contents

The Evidence Ledger at a Glance

Ranked against the popular narrative rather than with it. Note that each row states whether a claim is absent (never adequately tested) or negative (tested and failed) — these are different verdicts and collapsing them flatters the untested claim while unfairly damning the tested one.

1. Botanical identity of commercial material — UNVERIFIED. More than one species trades under the name; no species-level market survey located. This sits at the top because it conditions everything below it.
2. Adulteration of the product category with undeclared PDE5 inhibitors — ESTABLISHED, HUMAN. The best-evidenced hazard attached to buying this herb, and not a property of the plant at all.
3. Acetylcholinesterase inhibition in brain tissue after administration — ESTABLISHED PRECLINICALLY. The single strongest positive finding about this plant, from one programme, externally unreplicated.
4. Memory retrieval, anti-stress and neuroprotective effects — PRECLINICAL. Real, reasonably designed rodent and tissue work; no human counterpart of any kind.
5. Multi-ingredient blends improving sexual function — WEAK POSITIVE, UNATTRIBUTABLE. Published human results exist for formulas; none can be assigned to muira puama, whose dose is undisclosed.
6. Muira puama alone improving libido or erectile function — ABSENT. No randomised, placebo-controlled, single-herb trial using validated instruments. Not tested and failed; not tested.
7. Muira puama alone improving fatigue, mood or memory in people — ABSENT. Same position, despite the far better preclinical rationale.
8. Raising testosterone — UNTESTED IN HUMANS. Asserted in marketing; no human hormonal data located.
9. Identity of the active constituent — UNKNOWN. Ptychonal is the only structurally distinctive candidate; the sterols cannot be specific to this plant.
10. Human pharmacokinetics, reproductive toxicology, interaction studies, dose-finding — ALL ABSENT. Which is why "no known interactions" is a statement about missing research, not a reassurance.
11. Traditional use as aphrodisiac and nerve tonic — WELL DOCUMENTED AS TRADITION. Long, genuine, and not evidence of efficacy.

Read top to bottom, the ledger says something the marketing and the debunking both miss: the three best-established facts about muira puama are an identity problem, an adulteration problem, and a preclinical brain-pharmacology finding that has nothing to do with why anyone buys it.

Back to Table of Contents

How to Read This Deep Dive

A few conventions run through all four articles, and knowing them makes the pages faster to use.

• Absence of evidence is written as a finding, not left as a gap. Each article carries a numbered list of what is not known — missing toxicology, missing pharmacokinetics, missing dose-finding — so that "nobody has studied this" is a stated result rather than something you have to infer from silence.
• Borrowed evidence is labelled at every citation, not once in a preamble. Where a finding comes from a formula rather than the herb, from a different species, from a different plant part, from isolated tissue rather than a person, or from an ethanol extract where the tradition uses water, the label sits on the citation itself — because a reader arriving mid-page, or lifting one line, should carry the caveat along with the claim.
• Numbers we cannot stand behind are refused, and the refusal is stated. No invented milligram dose, no reprinted response percentages from an unretrievable source, no coumarin content per gram. Where sources disagree or a document cannot be checked, the article says so.
• Hazards are not manufactured either. The identity article and the safety article both include explicit lists of things muira puama is not guilty of — no pyrrolizidine alkaloids, no cyanogenic glycosides, no duration cap, no documented liver signal — because clearing a plant of a suspicion is as much a part of accuracy as raising one.
• Citations are PubMed topic searches rather than fixed records, so you see the current literature on a question rather than one paper chosen for you, and so that no citation can quietly rot into pointing at the wrong paper.
• Contradictions are reported as the story, not resolved in the flattering direction. The plant is characterised as anxiogenic in one study and anti-stress in others; it is sold simultaneously as a stimulant and as a calmative. Both tensions are named and left open where the evidence leaves them open.

Back to Table of Contents

Key Research: Botanical Identity and Authentication

The literature that decides whether any other result can be attached to the powder you can buy. Full discussion on Which Plant Is Muira Puama?

1. Ptychopetalum uncinatum in the literature. PubMed topic search — run it and note how little there is. A congener traded under the same common name as a much-studied relative, with almost no literature of its own, is the definition of an unverifiable substitution.
2. DNA barcoding for herbal identification. PubMed topic search — the methodological base establishing ITS2, rbcL and matK as workable identity tools. Their routine availability is what makes their absence here a funding choice rather than a limitation.
3. Metabarcoding surveys of commercial herbal products. PubMed topic search — repeated findings of declared species absent and undeclared species present across supplement markets. None specific to muira puama; all of it the base rate against which an unauthenticated Amazonian bark powder should be judged.
4. Marker-compound standardisation versus identity testing. PubMed topic search — the pharmacognosy distinction that underlies this whole deep dive's central technical argument.
5. Pharmacognostic authentication of powdered bark drugs. PubMed topic search — the methods behind the claim that powdered woody material is the hardest case for microscopy.
6. Amazonian medicinal bark harvest and sustainability. PubMed topic search — general literature on the harvest pattern this article belongs to. No population assessment specific to Ptychopetalum was located, and that gap is flagged rather than filled.

Back to Table of Contents

Key Research: The Sexual-Function Claim

Everything that exists, with its provenance labelled. Full discussion on Muira Puama for Libido.

1. Waynberg's clinical observations on muira puama. PubMed topic search — the near-absence of retrievable primary work is the finding. The presentation that anchors the herb's entire clinical reputation appears not to be indexed as a peer-reviewed article, and this deep dive deliberately does not assert its methods, patient numbers or response rates.
2. Waynberg J, Brewer S. "Effects of Herbal vX on libido and sexual activity in premenopausal and postmenopausal women." Advances in Therapy, 2000. Find on PubMed — formula substitution. A multi-ingredient product containing muira puama and Ginkgo biloba, studied in women, with the muira puama dose not usable by a reader. The most-quoted human evidence, and unattributable to this herb.
3. Antunes E and colleagues. "The relaxation of isolated rabbit corpus cavernosum by the herbal medicine Catuama and its constituents." Phytotherapy Research, 2001. Find on PubMed — formula, route and species substitution. A four-herb Brazilian product applied to excised rabbit tissue. Its individual-constituent arms are the part worth reading; the formula headline is the part usually quoted.
4. Composition of the Catuama formula. PubMed topic search — confirm which four species are actually in the product before accepting a claim that credits one of them. Verifying that a formula contains the herb, and in what company, is a step skipped remarkably often.
5. Rodent sexual-behaviour models and what they measure. PubMed topic search — methods. Mount and intromission latencies model copulatory mechanics, not human desire, and a centrally stimulating extract will improve them without any sexual specificity.
6. Validated sexual-function instruments. IIEF validation and FSFI validation — methods. The tools a real trial would use, which is what kills the "you cannot trial a traditional herb" defence.
7. Placebo response in sexual-medicine trials. PubMed topic search — methods. Why an uncontrolled open observation in this indication is uninformative rather than merely weak.

Back to Table of Contents

Key Research: Central Nervous System Pharmacology

The plant's real scientific record, and every item on it is preclinical. Full discussion on Muira Puama for Fatigue, Mood and Memory.

1. Siqueira IR and colleagues. "Ptychopetalum olacoides, a traditional Amazonian 'nerve tonic', possesses anticholinesterase activity." Pharmacology, Biochemistry and Behavior, 2003. Find on PubMed — rodent and enzyme. The mechanistic anchor of the whole programme, and the source of the cholinergic drug-interaction caution: benefit and hazard here are one property described twice.
2. Figueiró M and colleagues. "Acetylcholinesterase inhibition in cognition-relevant brain areas of mice treated with a nootropic Amazonian herbal (Marapuama)." Phytomedicine, 2010. Find on PubMed — rodent, in vivo. Stronger than an enzyme assay, because it shows action in brain tissue after administration.
3. da Silva AL and colleagues. "Memory retrieval improvement by Ptychopetalum olacoides in young and aging mice." Journal of Ethnopharmacology, 2004. Find on PubMed — rodent behaviour. Ageing mice are not a model of human age-associated memory complaint.
4. da Silva AL and colleagues. "Promnesic effects of Ptychopetalum olacoides in aversive and non-aversive learning paradigms." Journal of Ethnopharmacology, 2007. Find on PubMed — rodent behaviour. Including a non-aversive task is a genuine design strength and is credited as such.
5. Siqueira IR and colleagues. "Neuroprotective effects of Ptychopetalum olacoides Bentham (Olacaceae) on oxygen and glucose deprivation induced damage in rat hippocampal slices." Life Sciences, 2004. Find on PubMed — isolated tissue. Direct application to slices; no absorption, distribution or blood-brain barrier involved.
6. Piato AL and colleagues. "Antidepressant profile of Ptychopetalum olacoides Bentham (Marapuama) in mice." Phytotherapy Research, 2009. Find on PubMed — rodent behaviour. "Antidepressant-like" describes an assay result that stimulants also produce.
7. Piato AL and colleagues. "Anti-stress effects of the 'tonic' Ptychopetalum olacoides (Marapuama) in mice." Phytomedicine, 2010. Find on PubMed — rodent. The most direct test of the traditional adaptogen framing that exists anywhere.
8. Figueiró M and colleagues. "The Amazonian herbal Marapuama attenuates cognitive impairment and neuroglial degeneration in a mouse Alzheimer model." Phytomedicine, 2011. Find on PubMed — rodent disease model. Check the dosing schedule: pre-treatment makes this prevention, not treatment.
9. da Silva AL and colleagues. "Anxiogenic properties of Ptychopetalum olacoides Benth. (Marapuama)." Phytotherapy Research, 2002. Find on PubMed — rodent behaviour. The finding the marketing omits, and half of this deep dive's central contradiction.
10. Siqueira IR and colleagues. "Psychopharmacological properties of Ptychopetalum olacoides Bentham (Olacaceae)." Pharmaceutical Biology, 1998. Find on PubMed — rodent behaviour. The founding characterisation, describing a stimulant, tonic-like central profile.
11. Translational failure of Alzheimer mouse models. PubMed topic search — methods. Essential background for reading any "improved in an Alzheimer model" headline, this one included.

Back to Table of Contents

Key Research: Chemistry and the Missing Active Principle

The gap at the centre of every claim on this page: nobody knows which compound is responsible. Full discussion on Dose, Formulations and Safety.

1. Bucek EU, Fournier G, Dadoun H. "Volatile constituents of Ptychopetalum olacoides root oil." Planta Medica, 1987. Find on PubMed — chemistry, root. Note the plant part, in a trade that sells bark, root and stem under one name.
2. Nerve-growth-factor-potentiating diterpenoids from Ptychopetalum, including ptychonal. PubMed topic search — chemistry. The only structurally distinctive candidate for a specific central mechanism, and the best hope for a genuine identity marker. Author and journal metadata deliberately not asserted here: the primary reports are hard to verify from secondary sources, and a confident citation would be a guess.
3. Beta-sitosterol distribution across plants. PubMed topic search — chemistry. Enough to show why a beta-sitosterol result is not a muira puama result, and why an assay for it identifies "plant" rather than "this plant."
4. Beta-sitosterol pharmacology and the doses used. PubMed topic search — human, isolated compound. Read the doses, then ask whether a bark capsule could plausibly deliver them.
5. Coumarin, dicoumarol and the anticoagulant mechanism. PubMed topic search — pharmacology. Plain coumarin is not an anticoagulant; dicoumarol, from spoiled sweet clover, is. The basis for rejecting "contains coumarin, therefore thins blood."
6. Interspecies dose conversion by body surface area. PubMed topic search — methods. The convention behind the arithmetic showing a one-to-two-order-of-magnitude gap between studied and sold doses.

Back to Table of Contents

Key Research: Safety, Toxicology and Adulteration

Where the practical risk actually lives. Full discussion on Dose, Formulations and Safety.

1. Oliveira CH and colleagues. "Clinical toxicology study of an herbal medicinal extract of Paullinia cupana, Trichilia catigua, Ptychopetalum olacoides and Zingiber officinale (Catuama) in healthy volunteers." Phytotherapy Research, 2005. Find on PubMed — human, four-herb formula. The only human tolerability data touching this plant. Formula substitution applies, and guarana's caffeine confounds any stimulant-type endpoint in both directions.
2. Undeclared sildenafil and tadalafil in sexual-enhancement supplements. PubMed topic search — analytical. The evidence base for the category risk, and practically the most important literature in this whole deep dive.
3. Nitrate and PDE5 inhibitor interaction. PubMed topic search — clinical pharmacology. Why an undeclared PDE5 inhibitor is dangerous rather than merely dishonest, and why a man on nitrates is exactly the person most likely to reach for a "natural" alternative.
4. Coumarin hepatotoxicity and intake limits. PubMed topic search — toxicology. Where the real coumarin concern lies — hepatic, not haemostatic — and why the missing quantification for muira puama matters.
5. Herb–drug interaction assessment methods. PubMed topic search — methods. The standard screening never applied to this plant, which is why "unknown" rather than "none" is the correct interaction statement.
6. Under-reporting of herbal adverse events. PubMed topic search — pharmacovigilance. The evidence that "no case reports" reflects absent surveillance rather than demonstrated safety.
7. Heavy metals and contaminants in wild-harvested herbal material. PubMed topic search — analytical. Relevant to a woody drug traditionally prepared by prolonged boiling and never surveyed.
8. Erectile dysfunction as a cardiovascular marker. PubMed topic search — clinical. Why self-treating this symptom carries an opportunity cost larger than anything the bark itself is likely to do.

Back to Table of Contents

External Resources

• PubMed — the index behind every search on these pages.
• ClinicalTrials.gov — search muira puama and note what has never been registered.
• Plants of the World Online — Kew's accepted-name database, for checking Ptychopetalum and Liriosma nomenclature.
• World Flora Online — a second taxonomic opinion where synonymy is contested.
• National Center for Complementary and Integrative Health — plain-language assessments of what is and is not established for botanicals.
• FDA: Health Fraud Scams — public lists of products found to contain hidden drug ingredients, sexual-enhancement supplements prominent among them.
• MedlinePlus — the US National Library of Medicine's consumer health portal.
• Memorial Sloan Kettering: About Herbs — conservative, referenced monographs written for clinicians.
• United States Pharmacopeia and NSF — independent supplement verification programmes.

Back to Table of Contents

Connections

• All Herbs
• Muira Puama — main article
• Which Plant Is Muira Puama?
• Muira Puama for Libido
• Muira Puama for Fatigue, Mood and Memory
• Muira Puama: Dose, Formulations and Safety
• Damiana
• Damiana — Benefits Deep Dive
• Damiana: Aphrodisiac Claims Examined
• Tribulus
• Tribulus — Benefits Deep Dive
• Maca
• Maca: Libido and Sexual Function
• Epimedium
• Epimedium: The Icariin PDE5 Question
• Tongkat Ali
• Tongkat Ali: Product Quality and Adulteration
• Ginseng
• Ginseng: Erectile Function
• Ginkgo Biloba
• Ginkgo: Cognitive Function and Memory
• Ashwagandha
• Rhodiola Rosea
• Arginine: Erectile Function
• Erectile Dysfunction
• Low Testosterone and TRT
• Chronic Fatigue Syndrome

Back to Table of Contents